Warrier, Varun https://orcid.org/0000-0003-4532-8571
Stauffer, Eva-Maria
Huang, Qin Qin https://orcid.org/0000-0003-3073-717X
Wigdor, Emilie M.
Slob, Eric A. W. https://orcid.org/0000-0002-1644-0735
Seidlitz, Jakob https://orcid.org/0000-0002-8164-7476
Ronan, Lisa
Valk, Sofie L.
Mallard, Travis T.
Grotzinger, Andrew D. https://orcid.org/0000-0001-7852-9244
Romero-Garcia, Rafael https://orcid.org/0000-0002-5199-4573
Baron-Cohen, Simon https://orcid.org/0000-0001-9217-2544
Geschwind, Daniel H. https://orcid.org/0000-0003-2896-3450
Lancaster, Madeline A. https://orcid.org/0000-0003-2324-8853
Murray, Graham K. https://orcid.org/0000-0001-8296-1742
Gandal, Michael J. https://orcid.org/0000-0001-5800-5128
Alexander-Bloch, Aaron https://orcid.org/0000-0001-6554-1893
Won, Hyejung https://orcid.org/0000-0003-3651-0566
Martin, Hilary C. https://orcid.org/0000-0002-4454-9084
Bullmore, Edward T.
Bethlehem, Richard A. I. https://orcid.org/0000-0002-0714-0685
Article History
Received: 12 October 2022
Accepted: 13 July 2023
First Online: 17 August 2023
Competing interests
: A.A.-B. receives consulting income from Octave Biosciences. E.T.B. serves as a consultant for Sosei Heptares, Boehringer Ingelheim, GlaxoSmithKline, Monument Therapeutics and SR One. M.J.G. receives grant support from Mitsubishi Tanabe Pharma, unrelated to the current manuscript. The remaining authors declare no competing interests.